SOMA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Soma, and when can generic versions of Soma launch?
Soma is a drug marketed by Mylan Speciality Lp, Meda Pharms, and Ipsen Pharma. and is included in four NDAs.
The generic ingredient in SOMA is lanreotide acetate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lanreotide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Soma
A generic version of SOMA was approved as lanreotide acetate by INVAGEN PHARMS on December 17th, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOMA?
- What are the global sales for SOMA?
- What is Average Wholesale Price for SOMA?
Summary for SOMA
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Patent Applications: | 3,875 |
| Drug Prices: | Drug price information for SOMA |
| What excipients (inactive ingredients) are in SOMA? | SOMA excipients list |
| DailyMed Link: | SOMA at DailyMed |
Pharmacology for SOMA
| Drug Class | Muscle Relaxant |
| Physiological Effect | Centrally-mediated Muscle Relaxation |
US Patents and Regulatory Information for SOMA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | SOMA | carisoprodol | CAPSULE;ORAL | 011792-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipsen Pharma | SOMATULINE DEPOT | lanreotide acetate | SOLUTION;SUBCUTANEOUS | 022074-002 | Aug 30, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Meda Pharms | SOMA COMPOUND | aspirin; carisoprodol | TABLET;ORAL | 012365-005 | Jul 11, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ipsen Pharma | SOMATULINE DEPOT | lanreotide acetate | SOLUTION;SUBCUTANEOUS | 022074-003 | Aug 30, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Speciality Lp | SOMA | carisoprodol | TABLET;ORAL | 011792-004 | Sep 13, 2007 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Speciality Lp | SOMA | carisoprodol | TABLET;ORAL | 011792-001 | Approved Prior to Jan 1, 1982 | AA | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
